CAXII Is a sero-diagnostic marker for lung cancer.
To develop sero-diagnostic markers for lung cancer, we generated monoclonal antibodies using pulmonary adenocarcinoma (AD)-derived A549 cells as antigens by employing the random immunization method. Hybridoma supernatants were immunohistochemically screened for antibodies with AMeX-fixed and paraffi...
Guardado en:
Autores principales: | Makoto Kobayashi, Toshihide Matsumoto, Shinichiro Ryuge, Kengo Yanagita, Ryo Nagashio, Yoshitaka Kawakami, Naoki Goshima, Shi-Xu Jiang, Makoto Saegusa, Akira Iyoda, Yukitoshi Satoh, Noriyuki Masuda, Yuichi Sato |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f42a5fdb1ecd4432afc4c81d59c4e9e3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axis
por: Rui Han, et al.
Publicado: (2021) -
Derrame pleural sero-fibrinoso en un lactante tuberculoso negativo
por: OYARCE ROJAS,PEDRO, et al.
Publicado: (1949) -
Use of Soluble Extracellular Regions of MmpL (SERoM) as Vaccines for Tuberculosis
por: Emily J. Strong, et al.
Publicado: (2018) -
Integrated human-animal sero-surveillance of Brucellosis in the pastoral Afar and Somali regions of Ethiopia.
por: Rea Tschopp, et al.
Publicado: (2021) -
Stabilizing Genetically Unstable Simple Sequence Repeats in the <named-content content-type="genus-species">Campylobacter jejuni</named-content> Genome by Multiplex Genome Editing: a Reliable Approach for Delineating Multiple Phase-Variable Genes
por: Shouji Yamamoto, et al.
Publicado: (2021)